Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of Patient-Derived Tumor Organoids by SARS-CoV-2 Variants Across Cancer Types: A Study Combining Morphology, Inflammation, and Whole-Exome Profiling.

International journal of molecular sciences·2026
Same author

Risk Factors for Stricture After Endoscopic Submucosal Dissection of Large Rectal Neoplasms.

Diseases of the colon and rectum·2025
Same author

Later lines of systemic therapy in patients with metastatic colorectal cancer: real-world data from a setting with barriers to access cancer therapies.

Journal of gastrointestinal oncology·2025
Same author

Rectovaginal fistula: Which surgical technique do I choose?-A video vignette.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2024
Same author

An artificial intelligence-designed predictive calculator of conversion from minimally invasive to open colectomy in colon cancer.

Updates in surgery·2024
Same author

Predictors of lymph node metastasis and survival in radically resected rectal neuroendocrine tumors: A Surveillance, Epidemiology, and End Results (SEER) database analysis.

Surgery·2024

Related Experiment Video

Updated: Jun 17, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

Laparoscopic surgery for inflammatory bowel disease: does weight matter?

Jorge Canedo1, Rodrigo A Pinto, Sthela Regadas

  • 1Department of Colorectal Surgery, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL 33331, USA.

Surgical Endoscopy
|January 2, 2010
PubMed
Summary

Overweight and obese patients with inflammatory bowel disease (IBD) undergoing laparoscopic bowel resection experienced similar outcomes to normal-weight patients. Laparoscopic surgery benefits are not limited by body mass index (BMI) in IBD patients.

More Related Videos

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

Related Experiment Videos

Last Updated: Jun 17, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

Area of Science:

  • Colorectal Surgery
  • Inflammatory Bowel Disease (IBD)
  • Minimally Invasive Surgery

Background:

  • Laparoscopic colorectal surgery demonstrates improved outcomes compared to laparotomy for benign and malignant conditions, including Inflammatory Bowel Disease (IBD).
  • Obesity is a growing concern in surgical patient populations, necessitating evaluation of its impact on minimally invasive procedures.

Purpose of the Study:

  • To evaluate the outcomes of laparoscopic colorectal resections in normal weight versus overweight and obese patients with Inflammatory Bowel Disease (IBD).
  • To determine if elevated body mass index (BMI) affects conversion rates, postoperative complications, or hospital stay in laparoscopic IBD surgery.

Main Methods:

  • Retrospective analysis of a prospectively acquired surgical database of consecutive IBD patients undergoing laparoscopy.
  • Comparison of outcomes between normal weight (BMI 18.5-24.9 kg/m²) and overweight/obese (BMI ≥ 25 kg/m²) groups.
  • Statistical analysis using Chi-square, Mann-Whitney U test, and Student's t test to compare variables including 60-day postoperative complications.

Main Results:

  • No significant difference in conversion rates (18% vs. 22.09%) between normal weight and overweight/obese IBD patients.
  • Similar rates of major postoperative complications (wound infection, abscess, anastomotic leakage, small-bowel obstruction) and mean hospital stay (6.7 vs. 6.8 days).
  • No mortality observed in either group.

Conclusions:

  • Overweight and obese IBD patients undergoing laparoscopic bowel resection show comparable results to normal-weight patients.
  • Laparoscopic colorectal surgery is a viable option for IBD patients regardless of BMI.
  • BMI should not be a sole contraindication for offering laparoscopic bowel resection to IBD patients.